Corium Pharma Solutions | Gurnet Point Capital

Corium Pharma Solutions, Inc. is a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies, including transdermal modalities*.

Investment Date

2022

Fund

Fund II

Status

Current

Related News

March 1, 2023

Corium Pharma Solutions Names Suzanne Hinchliffe as Chief People Officer

Read

January 17, 2023

Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer

Read

October 20, 2022

Manufacturing Business Acquisition and a $100 Million Neuroscience Therapeutics Investment by Webster Equity Partners

Read

Fund II investments referenced herein have been completed by GPC through a warehouse facility provided by B-Flexion and are expected to be transferred to Fund II following its first closing. References to Fund II's investment activity to date are references to investments made by the warehouse facility.